查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1621372

小分子原料藥市場：按類型、產品、應用分類 - 全球預測 2025-2030

Small-Molecule APIs Market by Type (Biological, Synthetic), Production (Contract Manufacturing, In-House Manufacturing), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年小分子原料藥市值為1843.2億美元，預計2024年將達到1973.5億美元，複合年成長率為7.26%，到2030年將達到3011.9億美元。

小分子原料藥市場範圍包括對藥物製劑至關重要的多種藥物成分。這些分子是小的有機化合物，有助於診斷、治療和預防疾病。由於慢性病的增加、醫療基礎設施的擴大和世界人口的老化，對有效藥物的需求增加，對小分子原料藥的需求隨之而來。其用途廣泛，包括癌症、循環系統疾病、中樞神經系統疾病及感染疾病。最終用途範圍主要包括製藥和生物技術公司以及受託製造廠商(CMO)。市場成長很大程度上受到學名藥快速成長、重磅藥物專利到期以及藥物發現技術進步的影響。研發活動的活性化和有利的法律規範提供了更多潛在的商機。公司可以透過專注於個人化醫療和擴大其生物相似藥產品組合來利用這些機會。然而，挑戰包括嚴格的監管合規性、高投資成本和複雜的製造流程。眾多努力創新並贏得市場佔有率的參與者的出現也加劇了競爭格局。提供成長潛力的創新和研究領域包括連續製造流程、環保合成路線和先進的藥物傳輸系統。此外，人工智慧和機器學習在藥物設計和開發中的整合為業務擴展提供了新的途徑。關於市場性質的競爭考察強調了由技術進步和不斷變化的監管政策驅動的市場的動態和競爭性質。企業應優先考慮策略聯盟和持續創新以獲得優勢。透過解決關鍵挑戰並專注於永續實踐，公司可以成功駕馭市場並實現成長。

主要市場統計
基準年[2023] 1843.2億美元
預計年份 [2024] 1973.5億美元
預測年份 [2030] 3011.9億美元
複合年成長率（%） 7.26%

市場動態：快速發展的小分子原料藥市場的關鍵市場洞察

小分子原料藥市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 隨著世界老年人口的增加，慢性病的流行
    • 全球對學名藥的需求不斷成長
  • 市場限制因素
    • 小分子原料藥相關的高成本
  • 市場機會
    • 藥物發現和開發的持續進步
    • 與生物製藥公司合作進行聯合治療
  • 市場挑戰
    • 藥物研發嚴格的監管要求

波特五力：開拓小分子原料藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解小分子原料藥市場的外部影響

外部宏觀環境因素在塑造小分子原料藥市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解小分子原料藥市場的競爭狀況

小分子原料藥市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣小分子原料藥市場供應商績效評估

FPNV定位矩陣是評估小分子原料藥市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃小分子原料藥市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，小分子原料藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病增加和人口老化
      • 全球對學名藥的需求增加
    • 抑制因素
      • 小分子原料藥相關的高成本
    • 機會
      • 藥物發現和開發的持續進步
      • 與生物製藥公司合作進行聯合治療
    • 任務
      • 藥物研發嚴格的監管要求
  • 市場區隔分析
    • 類型：由於副作用較少，越來越多使用基於生物的小分子原料藥
    • 生產：增加內部製造以確保品質標準
    • 應用：腫瘤學的不斷進步將提高小分子原料藥的利用率。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章小分子原料藥市場：依類型

  • 生物
  • 合成

第7章 小分子原料藥市場創造者

  • 契約製造
  • 內部製造

第8章小分子原料藥市場：依應用分類

  • 心血管
  • 糖尿病
  • 免疫疾病
  • 腫瘤學

第9章北美及南美小分子原料藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太小分子原料藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲小分子原料藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Lonza 推出人工智慧服務以簡化候選藥物的路線探索
    • 無錫 STA 擴大 API反應器產能並將胜肽生產能力增加兩倍以滿足全球需求
    • Granules 投資 2.5 億美元新建綠色小分子 API 生產設施
    • SST Corporation與Viwit Pharmaceuticals建立策略聯盟
    • API 與滑鐵盧大學科學家合作開發針對冠狀病毒的廣譜小分子療法
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Alacrita Holdings Limited
  • Albemarle Corporation
  • Aspen Group
  • Astrazeneca PLC
  • Aurobindo Pharma Limited
  • Bachem Holding AG
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Cambrex Corporation by Permira funds
  • Carlyle Group
  • Charles River Laboratories International, Inc.
  • Deciphera Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd,
  • Gilead Sciences, Inc
  • GlaxoSmithKline PLC
  • Koninklijke DSM NV
  • Lonza Group AG
  • Merck KGaA
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-43539E5D3217

The Small-Molecule APIs Market was valued at USD 184.32 billion in 2023, expected to reach USD 197.35 billion in 2024, and is projected to grow at a CAGR of 7.26%, to USD 301.19 billion by 2030.

The scope of the Small-Molecule APIs market encompasses a wide range of pharmaceutical ingredients that are crucial for drug formulation. These molecules are small organic compounds that aid in the diagnosis, treatment, and prevention of diseases. The necessity for small-molecule APIs is driven by the increasing demand for effective medications due to rising chronic diseases, expanding healthcare infrastructure, and an aging global population. Their applications are vast, including oncology, cardiovascular, central nervous system disorders, and infectious diseases, among others. The end-use scope primarily covers pharmaceutical and biotechnology companies, as well as contract manufacturing organizations (CMOs). Market growth is influenced significantly by the surge in generic drug production, patent expirations of blockbuster drugs, and advancements in drug discovery technologies. Increased research and development activities and favorable regulatory frameworks further provide potential opportunities. Companies can capitalize on these opportunities by focusing on personalized medicine and expanding their biosimilars portfolio. However, limitations such as stringent regulatory compliance, high investment costs, and complex manufacturing processes present challenges. The competitive landscape is also intensified by the presence of numerous players striving for innovation and market share. Areas of innovation and research that offer growth potential include continuous manufacturing processes, eco-friendly synthesis routes, and advanced drug delivery systems. Additionally, integration of AI and machine learning in drug design and development presents new avenues for business expansion. Insights into the nature of the market highlight its dynamic and competitive nature, driven by technological advancements and evolving regulatory policies. Companies should prioritize strategic collaborations and continuous innovation to stay ahead. By addressing key challenges and focusing on sustainable practices, businesses can successfully navigate the market and achieve growth.

KEY MARKET STATISTICS
Base Year [2023] USD 184.32 billion
Estimated Year [2024] USD 197.35 billion
Forecast Year [2030] USD 301.19 billion
CAGR (%) 7.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Small-Molecule APIs Market

The Small-Molecule APIs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic diseases coupled with increasing geriatric population globally
    • Rising demand for generic drugs worldwide
  • Market Restraints
    • High cost associated with small-molecule APIs
  • Market Opportunities
    • Ongoing advancements in drug discovery and development
    • Collaborations with bio-pharmaceutical companies for combination therapies
  • Market Challenges
    • Stringent regulatory requirements for drug development

Porter's Five Forces: A Strategic Tool for Navigating the Small-Molecule APIs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Small-Molecule APIs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Small-Molecule APIs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Small-Molecule APIs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Small-Molecule APIs Market

A detailed market share analysis in the Small-Molecule APIs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Small-Molecule APIs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Small-Molecule APIs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Small-Molecule APIs Market

A strategic analysis of the Small-Molecule APIs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Small-Molecule APIs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Biological and Synthetic.
  • Based on Production, market is studied across Contract Manufacturing and In-House Manufacturing.
  • Based on Application, market is studied across Cardiovascular, Diabetes, Immunological Disorders, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
      • 5.1.1.2. Rising demand for generic drugs worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with small-molecule APIs
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in drug discovery and development
      • 5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for drug development
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
    • 5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
    • 5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Small-Molecule APIs Market, by Type

  • 6.1. Introduction
  • 6.2. Biological
  • 6.3. Synthetic

7. Small-Molecule APIs Market, by Production

  • 7.1. Introduction
  • 7.2. Contract Manufacturing
  • 7.3. In-House Manufacturing

8. Small-Molecule APIs Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Diabetes
  • 8.4. Immunological Disorders
  • 8.5. Oncology

9. Americas Small-Molecule APIs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Small-Molecule APIs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Small-Molecule APIs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Lonza Launches AI-Powered Service to Simplify Route Scouting for New Drug Candidates
    • 12.3.2. WuXi STA Expands API Reactor Volume and Triples Peptide Manufacturing Capacity to Meet Global Demand
    • 12.3.3. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
    • 12.3.4. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
    • 12.3.5. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Alacrita Holdings Limited
  • 4. Albemarle Corporation
  • 5. Aspen Group
  • 6. Astrazeneca PLC
  • 7. Aurobindo Pharma Limited
  • 8. Bachem Holding AG
  • 9. Bio-Rad Laboratories, Inc.
  • 10. Boehringer Ingelheim GmbH
  • 11. Bristol-Myers Squibb
  • 12. Cambrex Corporation by Permira funds
  • 13. Carlyle Group
  • 14. Charles River Laboratories International, Inc.
  • 15. Deciphera Pharmaceuticals, Inc.
  • 16. Dr. Reddy's Laboratories Ltd.
  • 17. F. Hoffmann-La Roche Ltd,
  • 18. Gilead Sciences, Inc
  • 19. GlaxoSmithKline PLC
  • 20. Koninklijke DSM N.V.
  • 21. Lonza Group AG
  • 22. Merck KGaA
  • 23. Pfizer, Inc.
  • 24. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
  • FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
  • TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023